Profile change history

What changed for Enfuvirtide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Enfuvirtide identity.

49Total events
49Record additions
0Version changes
16Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 49 connected records →

Showing the latest 49 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT00001118

PeptideScanner retained ClinicalTrials.gov record NCT00001118 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002228

PeptideScanner retained ClinicalTrials.gov record NCT00002228 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00002239

PeptideScanner retained ClinicalTrials.gov record NCT00002239 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-11-15, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00008528

PeptideScanner retained ClinicalTrials.gov record NCT00008528 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00021554

PeptideScanner retained ClinicalTrials.gov record NCT00021554 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00022763

PeptideScanner retained ClinicalTrials.gov record NCT00022763 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-02-15, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
February 15, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00031044

PeptideScanner retained ClinicalTrials.gov record NCT00031044 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00051831

PeptideScanner retained ClinicalTrials.gov record NCT00051831 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 1, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00086710

PeptideScanner retained ClinicalTrials.gov record NCT00086710 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2005
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00120367

PeptideScanner retained ClinicalTrials.gov record NCT00120367 at 2026-11-16T01:41:15.051Z. Its registry update date was 2026-04-02, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
April 2, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00302822

PeptideScanner retained ClinicalTrials.gov record NCT00302822 at 2026-11-16T01:41:15.051Z. Its registry update date was 2026-04-07, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
April 7, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00334022

PeptideScanner retained ClinicalTrials.gov record NCT00334022 at 2026-11-16T01:41:15.051Z. Its registry update date was 2012-06-05, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
June 5, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00344760

PeptideScanner retained ClinicalTrials.gov record NCT00344760 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-05-11, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
May 11, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00460382

PeptideScanner retained ClinicalTrials.gov record NCT00460382 at 2026-11-16T01:41:15.051Z. Its registry update date was 2010-09-17, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
September 17, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00487188

PeptideScanner retained ClinicalTrials.gov record NCT00487188 at 2026-11-16T01:41:15.051Z. Its registry update date was 2015-08-13, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
August 13, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00537394

PeptideScanner retained ClinicalTrials.gov record NCT00537394 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-04, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00624195

PeptideScanner retained ClinicalTrials.gov record NCT00624195 at 2026-11-16T01:41:15.051Z. Its registry update date was 2014-04-23, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
April 23, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00657761

PeptideScanner retained ClinicalTrials.gov record NCT00657761 at 2026-11-16T01:41:15.051Z. Its registry update date was 2008-04-14, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
April 14, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01836068

PeptideScanner retained ClinicalTrials.gov record NCT01836068 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-23, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 23, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02569502

PeptideScanner retained ClinicalTrials.gov record NCT02569502 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-11-02, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
November 2, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02582983

PeptideScanner retained ClinicalTrials.gov record NCT02582983 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-07-06, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
July 6, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02733419

PeptideScanner retained ClinicalTrials.gov record NCT02733419 at 2026-11-16T01:41:15.051Z. Its registry update date was 2016-04-11, and PeptideScanner's reviewed identity mapping was enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
April 11, 2016
Evidence lane
Clinical trials
Record added

Federal Register notice E6-15554

The Federal Register published notice E6-15554, attributed to FDA and its parent HHS department, on 2006-09-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FUZEON,” and PeptideScanner's exact reviewed identity mapping connects the document to Enfuvirtide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2006
Evidence lane
Regulatory
Record added

Enfuvirtide.

PubMed lists PMID 12457443 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2002-12 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 16, 2019
Evidence lane
Literature metadata
Record added

Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.

PubMed lists PMID 12562683 in The Journal of antimicrobial chemotherapy as Journal Article, Review, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 13, 2019
Evidence lane
Literature metadata
Record added

Enfuvirtide.

PubMed lists PMID 14664654 in Drugs as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 11, 2026
Evidence lane
Literature metadata
Record added

Enfuvirtide: antiretroviral class 4, drug 1.

PubMed lists PMID 15002081 in HIV clinical trials as Journal Article, Review, with publication-date metadata of 2004 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Enfuvirtide.

PubMed lists PMID 15148534 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2004-03 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 8, 2019
Evidence lane
Literature metadata
Record added

Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.

PubMed lists PMID 15199084 in Journal of clinical pharmacology as Clinical Trial, Journal Article, with publication-date metadata of 2004-07 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure.

PubMed lists PMID 15258964 in Journal of medical virology as Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 30, 2018
Evidence lane
Literature metadata
Record added

Immunological and virological study of enfuvirtide-treated HIV-positive patients.

PubMed lists PMID 15280778 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-08-20 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 18, 2019
Evidence lane
Literature metadata
Record added

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.

PubMed lists PMID 15316339 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2004-09-03 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 18, 2019
Evidence lane
Literature metadata
Record added

Enfuvirtide (T-20): potentials and challenges.

PubMed lists PMID 15538017 in The Journal of the Association of Nurses in AIDS Care : JANAC as Journal Article, Review, with publication-date metadata of 2004 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Pharmacokinetics of enfuvirtide in pediatric human immunodeficiency virus 1-infected patients receiving combination therapy.

PubMed lists PMID 15626952 in The Pediatric infectious disease journal as Clinical Trial, Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Multicenter Study, and 1 more PubMed publication type, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Therapeutic indications, antiretroviral treatment optimization and quality of life of patients taking enfuvirtide].

PubMed lists PMID 15742551 in Medecine et maladies infectieuses as Journal Article, Review, with publication-date metadata of 2004-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Enfuvirtide: first drug of a new family of antiretroviral agents].

PubMed lists PMID 16433570 in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria as Journal Article, Review, with publication-date metadata of 2005 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 9, 2019
Evidence lane
Literature metadata
Record added

Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2.

PubMed lists PMID 16706613 in AIDS research and human retroviruses as Clinical Trial, Phase III, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2006-05 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2006
Evidence lane
Literature metadata
Record added

A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.

PubMed lists PMID 16759047 in Antiviral therapy as Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Enfuvirtide antiviral activity despite rebound viremia and resistance mutations: fitness tampering or a case of persistent braking on entering?

PubMed lists PMID 17205468 in The Journal of infectious diseases as Editorial, Review, Comment, with publication-date metadata of 2006-12-21 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Anti-HIV agents. T-20 (enfurvirtide, Fuzeon).

PubMed lists PMID 17225316 in TreatmentUpdate as Controlled Clinical Trial, Journal Article, Newspaper Article, with publication-date metadata of 2005 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

[Spanish recommendations for proper use of enfuvirtide].

PubMed lists PMID 17288910 in Enfermedades infecciosas y microbiologia clinica as Consensus Statement, Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2007-02 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.

PubMed lists PMID 17389560 in Journal of clinical pharmacology as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2007-04 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 3, 2021
Evidence lane
Literature metadata
Record added

Reassessment of enfuvirtide's role in the management of HIV-1 infection.

PubMed lists PMID 18710359 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2008-09 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 17, 2019
Evidence lane
Literature metadata
Record added

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients.

PubMed lists PMID 19461505 in AIDS (London, England) as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-07-17 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.

PubMed lists PMID 20001856 in The Journal of infectious diseases as Clinical Trial, Journal Article, with publication-date metadata of 2010-01-15 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 29, 2025
Evidence lane
Literature metadata
Record added

Enfuvirtide: from basic investigations to current clinical use.

PubMed lists PMID 20977403 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2010-11 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Enfuvirtide biosynthesis in thermostable chaperone-based fusion.

PubMed lists PMID 35646620 in Biotechnology reports (Amsterdam, Netherlands) as Journal Article, with publication-date metadata of 2022-05-14 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 16, 2022
Evidence lane
Literature metadata
Record added

Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel.

PubMed lists PMID 37120679 in Drug delivery and translational research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-04-29 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 5, 2023
Evidence lane
Literature metadata